ADLEAP(enzalutamide)
Therapeutic class: androgen receptor inhibitors
Indication: Castration-resistant prostate cancer, Metastatic castration-sensitive prostate cancer
160 mg tablets & 40 mg Capsules
160 mg:-
A strip of 7 tablets40 mg:-
A bottle of 28 Capsules- 20°C to 25°C (68°F to 77°F), Shelf Life: 2 Years
- As directed by physician
